Bank of Montreal
PVLA

Bank of Montreal’s Palvella Therapeutics PVLA Stock Holding History

Bank of Montreal’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-6,022
Closed -$501K – 4270
2022
Q4 		$501K Buy
+6,022
New +$484K ﹤0.01% 2611
2022
Q3 		– Sell
-9,869
Closed -$2.6K – 4471
2022
Q2 		$2.6K Buy
+9,869
New +$1.8M ﹤0.01% 1764
2021
Q2 		– Sell
-18
Closed -$4K – 5021
2021
Q1 		$4K Sell
18
-84
-82% -$18.4K ﹤0.01% 4770
2020
Q4 		$23K Buy
102
+73
+252% +$15.2K ﹤0.01% 4364
2020
Q3 		$5K Sell
29
-20
-41% -$4.55K ﹤0.01% 4457
2020
Q2 		$11K Buy
+49
New +$11.5K ﹤0.01% 4140
2020
Q1 		– Sell
-71
Closed -$20K – 4808
2019
Q4 		$20K Buy
71
+14
+25% +$3.88K ﹤0.01% 4322
2019
Q3 		$16K Buy
57
+8
+16% +$3.1K ﹤0.01% 4217
2019
Q2 		$18K Buy
+49
New +$14.6K ﹤0.01% 4250
2019
Q1 		– Sell
-9
Closed -$2K – 4812
2018
Q4 		$2K Buy
9
+5
+125% +$1.55K ﹤0.01% 4430
2018
Q3 		$2K Sell
4
-1
-20% -$435 ﹤0.01% 4409
2018
Q2 		$2K Sell
5
-433
-99% -$206K ﹤0.01% 4413
2018
Q1 		$239K Buy
438
+199
+83% +$123K ﹤0.01% 2554
2017
Q4 		$144K Buy
+239
New +$111K ﹤0.01% 2835

Other funds holding PVLA

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Bank of Montreal's PVLA Position: Q1 2023 in Review

Bank of Montreal sold out of Palvella Therapeutics (PVLA) in Q1 2023, closing a stake of 6,022 shares — an estimated $501K sold.

Bank of Montreal first reported a position in PVLA in Q4 2017 and held it in 14 quarters. The position peaked at $501K in Q4 2022. 60 funds tracked by Wall St. Rank hold PVLA as of Q1 2023.

  • Bank of Montreal reported no remaining Palvella Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Bank of Montreal sold 6,022 Palvella Therapeutics shares in Q1 2023, an estimated $501K.
  • Bank of Montreal first reported a position in Palvella Therapeutics in Q4 2017 and held it in 14 quarters.
  • Bank of Montreal's Palvella Therapeutics position peaked at $501K in Q4 2022.
  • 60 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q1 2023.

Based on Bank of Montreal's 13F filing for Q1 2023, filed 13 Jun 2024.